Cooperative interaction of CTGF and TGF-β in animal models of fibrotic disease
2011

CTGF and TGF-β Interaction in Fibrosis

Sample size: 40 publication 10 minutes Evidence: moderate

Author Information

Author(s): Wang Qingjian, Usinger William, Nichols Blake, Gray Julia, Xu Leon, Seeley Todd W, Brenner Mitch, Guo Guangjie, Zhang Weihua, Oliver Noelynn, Lin Al, Yeowell David

Primary Institution: FibroGen Inc.

Hypothesis

The study examines the cooperative interaction of CTGF and TGF-β in fibrotic disease models.

Conclusion

CTGF and TGF-β work together to cause tissue fibrosis, and blocking CTGF with FG-3019 can reduce this fibrosis.

Supporting Evidence

  • CTGF and TGF-β2 together caused significant fibrosis in multiple organs.
  • Blocking CTGF with FG-3019 reduced fibrosis in all tested models.
  • Fibrosis was not observed when either CTGF or TGF-β2 was administered alone.

Takeaway

CTGF and TGF-β are like two friends that help each other make scars in the body, and a special medicine can help stop them from doing that.

Methodology

The study used three murine models of fibrosis and administered CTGF and TGF-β2 to observe fibrotic responses.

Potential Biases

Potential bias due to all authors being affiliated with FibroGen.

Limitations

The study was limited to animal models, and the effects in humans may differ.

Participant Demographics

Male Swiss Webster and C57BL/6 mice were used in the study.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1755-1536-4-4

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication